# Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)

> **NCT03876951** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Centre Georges Francois Leclerc** · enrollment: 67 (estimated)

## Conditions studied

- Vacuum-assisted Biopsy

## Interventions

- **DIAGNOSTIC_TEST:** Vacuum-assisted biopsy

## Key facts

- **NCT ID:** NCT03876951
- **Lead sponsor:** Centre Georges Francois Leclerc
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-08-30
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-04-08
- **Target enrollment:** 67 (ESTIMATED)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03876951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03876951, "Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03876951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*